Evidence map›Paper›PMID 32701653›Full record

ArticlePain2021

Netrin-1 receptor DCC is required for the contralateral topography of lamina I anterolateral system neurons.

Farin B Bourojeni, Hanns Ulrich Zeilhofer, Artur Kania

Open access · hybridAbstract read
In one paragraph

Article in Pain, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Farin B BourojeniResearch Unit in Neural Circuit Development, Institut de Recherches Cliniques de Montréal (IRCM), Montréal, QC, Canada.
Hanns Ulrich ZeilhoferInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Artur KaniaResearch Unit in Neural Circuit Development, Institut de Recherches Cliniques de Montréal (IRCM), Montréal, QC, Canada.
ETH Zurich · CHMcGill University · CAMontreal Clinical Research Institute · CA

Funding

CIHR PJT-153053CIHR PJT-159839CIHR PJT-162225
6 · The paper itself

Abstract

Anterolateral system (AS) neurons relay nociceptive information from the spinal cord to the brain, protecting the body from harm by evoking a variety of behaviours and autonomic responses. The developmental programs that guide the connectivity of AS neurons remain poorly understood. Spinofugal axons cross the spinal midline in response to Netrin-1 signalling through its receptor deleted in colorectal carcinoma (DCC); however, the relevance of this canonical pathway to AS neuron development has only been demonstrated recently. Here, we disrupted Netrin-1:DCC signalling developmentally in AS neurons and assessed the consequences on the path finding of the different classes of spinofugal neurons. Many lamina I AS neurons normally innervate the lateral parabrachial nucleus and periaqueductal gray on the contralateral side. The loss of DCC in the developing spinal cord resulted in increased frequency of ipsilateral projection of spinoparabrachial and spinoperiaqueductal gray neurons. Given that contralateral spinofugal projections are largely associated with somatotopic representation of the body, changes in the laterality of AS spinofugal projections may contribute to reduced precision in pain localization observed in mice and humans carrying Dcc mutations.

Indexed as

Nerve Growth FactorsTumor Suppressor ProteinsAnimalsAxonsDCC ReceptorMiceNetrin-1Netrin ReceptorsNeuronsReceptors, Cell SurfaceSpinal CordSpinal Cord Dorsal HornDcc protein, mouseDCC ReceptorNerve Growth FactorsNetrin-1Netrin ReceptorsNtn1 protein, mouseReceptors, Cell SurfaceTumor Suppressor Proteins

Identifiers

PMID32701653
PMCPMC7737868
OpenAlexW3045138702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.